{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:18:56Z","timestamp":1787681936306,"version":"build-2784847793"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI097312"],"award-info":[{"award-number":["R37 AI097312"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31AI188753"],"award-info":[{"award-number":["F31AI188753"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI007046"],"award-info":[{"award-number":["T32AI007046"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R41AI179576"],"award-info":[{"award-number":["R41AI179576"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R41AI179576"],"award-info":[{"award-number":["R41AI179576"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Gonorrhea is the second most common bacterial sexually transmitted infection and affects about 80 million people worldwide annually. The causative agent,\n                    <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                    , has become resistant to almost every antibiotic used for its treatment. There is no licensed vaccine against gonorrhea. Therefore, there is an urgent need to develop novel prevention and treatment strategies to curb the spread of gonorrhea. The gonococcus has evolved several mechanisms to evade complement, a key arm of immune defenses against this pathogen, including binding of the human complement inhibitors Factor H (FH) and C4b-binding protein (C4BP). We previously showed that chimeric molecules fusing the gonococcal binding domains of FH and C4BP to IgG Fc and IgM Fc, respectively, mediate complement-dependent killing of gonococci in vitro and attenuate gonococcal colonization of mouse vaginas when administered topically. Here, we fused C4BP domains 1 and 2, which contain the gonococcal binding region, to IgG Fc bearing the IgM tail-piece to facilitate Fc hexamerization. This molecule, called C4BP-Hexa IgG Fc, showed ~650-fold greater complement-dependent bactericidal activity on a molar basis than monomeric C4BP-IgG1 Fc. C4BP-Hexa IgG Fc enhanced association with and uptake by human neutrophils in a complement-independent manner. Despite \u2018off-target\u2019 complement activation in solution, C4BP-Hexa IgG Fc reduced both the duration and the bacterial burden of gonococcal vaginal colonization in human FH and C4BP transgenic mice when administered intravaginally daily. In conclusion, we show proof-of-concept of the efficacy of a hexameric C4BP IgG Fc fusion molecule against\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    , which could aid in the fight against this multidrug-resistant pathogen.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0350782","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:26:12Z","timestamp":1787678772000},"page":"e0350782","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae"],"prefix":"10.1371","volume":"21","author":[{"given":"Jutamas","family":"Shaughnessy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Wakim","family":"Broden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Telford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4980-868X","authenticated-orcid":true,"given":"Sandy P.","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3640-4995","authenticated-orcid":true,"given":"Y.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5343-5329","authenticated-orcid":true,"given":"Keith L.","family":"Wycoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-6803","authenticated-orcid":true,"given":"Kevin J.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7738-3757","authenticated-orcid":true,"given":"Alison K.","family":"Criss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0058-9532","authenticated-orcid":true,"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"pone.0350782.ref001","unstructured":"World Health Organization. World Health Organization. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis"},{"issue":"6","key":"pone.0350782.ref002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005792-198311000-00005","article-title":"Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms","volume":"62","author":"JP O\u2019Brien","year":"1983","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"pone.0350782.ref003","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-74-6-979","article-title":"Disseminated gonococcal infection","volume":"74","author":"KK Holmes","year":"1971","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0350782.ref004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"M Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"pone.0350782.ref005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"M Unemo","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"50","key":"pone.0350782.ref006","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s Treatment Guidelines for Gonococcal Infection, 2020","volume":"69","author":"S St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"pone.0350782.ref007","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/jac\/dkz129","article-title":"Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates","volume":"74","author":"K Lee","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"pone.0350782.ref008","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"M Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pone.0350782.ref009","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"M Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pone.0350782.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00785-5","article-title":"Novel strain of multidrug non-susceptible Neisseria gonorrhoeae in the USA","volume":"24","author":"JL Reimche","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"pone.0350782.ref011","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1408109","article-title":"A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia","volume":"371","author":"MM Lahra","year":"2014","journal-title":"N Engl J Med"},{"key":"pone.0350782.ref012","first-page":"101663","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study","volume":"61","author":"I Maatouk","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"pone.0350782.ref013","article-title":"High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024","volume":"232","author":"JGE Laumen","year":"2025","journal-title":"J Infect Dis"},{"issue":"10524","key":"pone.0350782.ref014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(25)01953-1","article-title":"Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial","volume":"407","author":"A Luckey","year":"2026","journal-title":"The Lancet"},{"issue":"10489","key":"pone.0350782.ref015","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","article-title":"Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study","volume":"405","author":"JDC Ross","year":"2025","journal-title":"Lancet"},{"key":"pone.0350782.ref016","unstructured":"U.S. Food and Drug Administration. 2025. [cited 2025 Dec 12]https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-two-oral-therapies-treat-gonorrhea"},{"issue":"12","key":"pone.0350782.ref017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01221-18","article-title":"Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae","volume":"62","author":"NE Scangarella-Oman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0350782.ref018","article-title":"Zoliflodacin and gepotidacin cross-resistance in Neisseria gonorrhoeae","author":"A Mukherjee","year":"2025","journal-title":"bioRxiv"},{"issue":"3","key":"pone.0350782.ref019","article-title":"Susceptibility trends of zoliflodacin against multidrug-resistant Neisseria gonorrhoeae clinical isolates in Nanjing, China, 2014 to 2018","volume":"65","author":"W Le","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pone.0350782.ref020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","article-title":"Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study","volume":"22","author":"WE Abara","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pone.0350782.ref021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/infdis\/jiae383","article-title":"Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and meta-analysis","volume":"231","author":"WE Abara","year":"2025","journal-title":"J Infect Dis"},{"issue":"26","key":"pone.0350782.ref022","doi-asserted-by":"crossref","first-page":"126312","DOI":"10.1016\/j.vaccine.2024.126312","article-title":"Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study","volume":"42","author":"WE Abara","year":"2024","journal-title":"Vaccine"},{"issue":"10102","key":"pone.0350782.ref023","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"H Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"pone.0350782.ref024","article-title":"Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California","author":"KJ Bruxvoort","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0350782.ref025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa2516739","article-title":"Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection","volume":"395","author":"KL Seib","year":"2026","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0350782.ref026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41541-026-01422-y","article-title":"Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO)","volume":"11","author":"C Thng","year":"2026","journal-title":"NPJ Vaccines"},{"key":"pone.0350782.ref027","doi-asserted-by":"crossref","first-page":"1248613","DOI":"10.3389\/fimmu.2023.1248613","article-title":"Immune responses to Neisseria gonorrhoeae and implications for vaccine development","volume":"14","author":"T Belcher","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0350782.ref028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"JE Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"pone.0350782.ref029","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","article-title":"Infections of people with complement deficiencies and patients who have undergone splenectomy","volume":"23","author":"S Ram","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"pone.0350782.ref030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.193.3.281","article-title":"Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae","volume":"193","author":"S Ram","year":"2001","journal-title":"J Exp Med"},{"issue":"4","key":"pone.0350782.ref031","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.188.4.671","article-title":"Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae","volume":"188","author":"S Ram","year":"1998","journal-title":"J Exp Med"},{"issue":"5","key":"pone.0350782.ref032","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.187.5.743","article-title":"A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae","volume":"187","author":"S Ram","year":"1998","journal-title":"J Exp Med"},{"key":"pone.0350782.ref033","doi-asserted-by":"crossref","first-page":"975676","DOI":"10.3389\/fimmu.2022.975676","article-title":"An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae","volume":"13","author":"J Shaughnessy","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0350782.ref034","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.1500292","article-title":"A novel factor H-Fc chimeric immunotherapeutic molecule against Neisseria gonorrhoeae","volume":"196","author":"J Shaughnessy","year":"2016","journal-title":"J Immunol"},{"issue":"9","key":"pone.0350782.ref035","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.4049\/jimmunol.1701666","article-title":"Human factor H domains 6 and 7 fused to IgG1 Fc are immunotherapeutic against Neisseria gonorrhoeae","volume":"201","author":"J Shaughnessy","year":"2018","journal-title":"J Immunol"},{"key":"pone.0350782.ref036","doi-asserted-by":"crossref","first-page":"583305","DOI":"10.3389\/fimmu.2020.583305","article-title":"Development of complement factor H-based immunotherapeutic molecules in tobacco plants against multidrug-resistant Neisseria gonorrhoeae","volume":"11","author":"J Shaughnessy","year":"2020","journal-title":"Front Immunol"},{"issue":"23","key":"pone.0350782.ref037","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131886","article-title":"C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections","volume":"4","author":"S Bettoni","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"pone.0350782.ref038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0038-1647294","article-title":"Identification of different forms of human C4b-binding protein lacking beta-chain and protein S binding ability","volume":"64","author":"M Hessing","year":"1990","journal-title":"Thromb Haemost"},{"issue":"1","key":"pone.0350782.ref039","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s42003-021-02513-3","article-title":"On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation","volume":"4","author":"JM Sopp","year":"2021","journal-title":"Commun Biol"},{"issue":"4","key":"pone.0350782.ref040","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1104\/pp.107.106377","article-title":"TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector","volume":"145","author":"JA Lindbo","year":"2007","journal-title":"Plant Physiol"},{"key":"pone.0350782.ref041","article-title":"Structure of IgG-Fc hexamer reveals a mutual lock-and-key mode of Fc-Fc interaction","author":"D Yuan","year":"2022","journal-title":"bioRxiv"},{"key":"pone.0350782.ref042","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.mie.2021.05.011","article-title":"Manufacturing plant-made monoclonal antibodies for research or therapeutic applications","volume":"660","author":"K Swope","year":"2021","journal-title":"Methods Enzymol"},{"issue":"2","key":"pone.0350782.ref043","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/iai.32.2.641-648.1981","article-title":"Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen","volume":"32","author":"I Nachamkin","year":"1981","journal-title":"Infect Immun"},{"issue":"6","key":"pone.0350782.ref044","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.174.6.1601","article-title":"Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men","volume":"174","author":"H Schneider","year":"1991","journal-title":"J Exp Med"},{"issue":"51","key":"pone.0350782.ref045","doi-asserted-by":"crossref","first-page":"36550","DOI":"10.1074\/jbc.274.51.36550","article-title":"Structural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitopes","volume":"274","author":"R Yamasaki","year":"1999","journal-title":"J Biol Chem"},{"issue":"13","key":"pone.0350782.ref046","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/JB.00171-13","article-title":"Constitutively Opa-expressing and Opa-deficient neisseria gonorrhoeae strains differentially stimulate and survive exposure to human neutrophils","volume":"195","author":"LM Ball","year":"2013","journal-title":"J Bacteriol"},{"key":"pone.0350782.ref047","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4939-9496-0_16","article-title":"Complement-dependent serum bactericidal assays for Neisseria gonorrhoeae","volume":"1997","author":"S Gulati","year":"2019","journal-title":"Methods Mol Biol"},{"key":"pone.0350782.ref048","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-9496-0_19","article-title":"Protocols to interrogate the interactions between Neisseria gonorrhoeae and primary human neutrophils","volume":"1997","author":"SA Ragland","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"12","key":"pone.0350782.ref049","article-title":"Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine","volume":"91","author":"MC Gray","year":"2023","journal-title":"Infect Immun"},{"issue":"4","key":"pone.0350782.ref050","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00035-22","article-title":"Variable expression of opa proteins by Neisseria gonorrhoeae influences bacterial association and phagocytic killing by human neutrophils","volume":"204","author":"AM Alcott","year":"2022","journal-title":"J Bacteriol"},{"key":"pone.0350782.ref051","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-0716-0154-9_10","article-title":"Using imaging flow cytometry to quantify neutrophil phagocytosis","volume":"2087","author":"A Smirnov","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"3","key":"pone.0350782.ref052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011055","article-title":"Neisseria gonorrhoeae co-opts C4b-binding protein to enhance complement-independent survival from neutrophils","volume":"19","author":"LM Werner","year":"2023","journal-title":"PLoS Pathog"},{"issue":"6","key":"pone.0350782.ref053","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1189\/jlb.0805456","article-title":"Aggregated IgG inhibits the differentiation of human fibrocytes","volume":"79","author":"D Pilling","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"7","key":"pone.0350782.ref054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005043","article-title":"Virulence of Group A streptococci is enhanced by human complement inhibitors","volume":"11","author":"D Ermert","year":"2015","journal-title":"PLoS Pathog"},{"issue":"7","key":"pone.0350782.ref055","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.chom.2025.05.015","article-title":"Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolism","volume":"33","author":"EA Kurt-Jones","year":"2025","journal-title":"Cell Host Microbe"},{"key":"pone.0350782.ref056","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-4939-9496-0_24","article-title":"Female mouse model of Neisseria gonorrhoeae infection","volume":"1997","author":"EL Raterman","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"25","key":"pone.0350782.ref057","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1073\/pnas.93.25.14851","article-title":"CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins","volume":"93","author":"T Chen","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pone.0350782.ref058","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/emboj\/16.12.3435","article-title":"CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes","volume":"16","author":"SD Gray-Owen","year":"1997","journal-title":"EMBO J"},{"issue":"6176","key":"pone.0350782.ref059","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"CA Diebolder","year":"2014","journal-title":"Science"},{"issue":"47","key":"pone.0350782.ref060","doi-asserted-by":"crossref","first-page":"17142","DOI":"10.1073\/pnas.0506471102","article-title":"Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection","volume":"102","author":"J Ngampasutadol","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0350782.ref061","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.4049\/jimmunol.180.5.3426","article-title":"Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion","volume":"180","author":"J Ngampasutadol","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"pone.0350782.ref062","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40259-025-00720-6","article-title":"Understanding IgM structure and biology to engineer new antibody therapeutics","volume":"39","author":"J Buchner","year":"2025","journal-title":"BioDrugs"},{"issue":"1","key":"pone.0350782.ref063","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0015-0282(16)44117-8","article-title":"The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies","volume":"32","author":"RJ Price","year":"1979","journal-title":"Fertil Steril"},{"issue":"6","key":"pone.0350782.ref064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000323","article-title":"Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody","volume":"17","author":"S Gulati","year":"2019","journal-title":"PLoS Biol"},{"issue":"8","key":"pone.0350782.ref065","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/humrep\/12.8.1826","article-title":"Volumetric self-sampling of cervicovaginal fluid to determine potential fertility: a multicentre pre-effectiveness study of the Rovumeter","volume":"12","author":"AM Flynn","year":"1997","journal-title":"Hum Reprod"},{"issue":"1","key":"pone.0350782.ref066","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF01204108","article-title":"Correlation of cervicovaginal fluid volume with serum estradiol levels and total follicular volume during human gonadotropin stimulation","volume":"9","author":"DE Pratt","year":"1992","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"pone.0350782.ref067","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0015-0282(16)46876-7","article-title":"Volumetric self-sampling of cervicovaginal fluid: a new approach to ovulation timing","volume":"39","author":"SJ Usala","year":"1983","journal-title":"Fertil Steril"},{"issue":"1","key":"pone.0350782.ref068","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s41467-024-46321-9","article-title":"Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria","volume":"15","author":"S Foss","year":"2024","journal-title":"Nat Commun"},{"key":"pone.0350782.ref069","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2334-10-323","article-title":"Predominant porB1A and porB1B genotypes and correlation of gene mutations with drug resistance in Neisseria gonorrhoeae isolates in Eastern China","volume":"10","author":"A Sun","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"7","key":"pone.0350782.ref070","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae389","article-title":"a meta-analysis to quantify the risk of disseminated gonococcal infection with Porin B Serotype","volume":"11","author":"G Welch","year":"2024","journal-title":"Open Forum Infect Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:26:21Z","timestamp":1787678781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350782"}},"subtitle":[],"editor":[{"given":"Fiona J","family":"Radcliff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350782","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}